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SUMMARY 
Objective: To investigate the prevalence of Hepatitis B 
and C infections and co-infections among blood donors 
in a rural community of Ghana. 
Design: A retrospective study. 
Method: Samples of blood donated between January 
2007 and December 2008 were screen for Hepatitis B 
and C viruses at the Agogo Presbyterian Hospital.  
Results: The prevalence of Hepatitis B viral (HBV) 
infection was highest in females 21.4% (95% CI: 11.6-
34.4) in 2006 than males in the same year 13.2% (95% 
CI: 10.8-15.9). Hepatitis C viral (HCV) infection was 
highest among males at11.6% (95% CI: 9.5-13.8) in 
2007. HBV and HCV co-infection was higher in males 
2.6% (95% CI: 1.6-3.8) than females 1.3% (95% CI: 0-
7.0) in 2007. The overall prevalence of HBV and HCV 
was 13.8% (95% CI: 11.4-16.4) and 9.4% (95% CI: 
7.4-11.6) respectively in 2006. The rate of co-infection 
of HBV and HCV however increased from 1.6% (95% 
CI: 0.8-2.7) in 2006 to 2.2% (95% CI: 1.3-3.2) in 2008 
in males and from 0% (95% CI: 0-6.4) in 2006 to 1.2% 
(95% CI: 0-6.5) in 2008 in females. 
Conclusion: The single infections of HBV and HCV 
reduced but co-infection of these transfusion 
transmitted infections (TTI) increased. Measures such 
as more sensitive techniques and education must be 
employed in these areas.   
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INTRODUCTION 
Hepatitis B is one of most common infectious diseases 
of the world infecting two billion people including an 
estimated 400 million chronically infected cases 1. 
Individuals with chronic infection have a high risk of 
developing liver cirrhosis and hepato cellular 
carcinoma. Hepatitis C virus infection is another 
common chronic blood borne infection with an 
estimated 3.9 million persons infected with the virus 
and has a high rate of development of liver cirrhosis. 
Infection by Hepatitis B virus (HBV) and Hepatitis C 
virus (HCV) cause serious mortality, morbidity and 
financial burden and are thus a major global health 
problem.2 Few studies have previously indicated the 
high prevalence of HBV in Ghana3,4and pre-donation 
screening of blood donors or screening of donated 
blood for HBV and HCV are thus a routine practice. 
HCV is recognized as the primary cause of transfusion-
associated non-A-non-B viral hepatitis worldwide5 and 
is endemic in West Africa.6  
 
In 1996, Martinson and his group conducted a sero-
epidemiological survey of Hepatitis B and C virus 
infections in school children in Ashanti-Akim North 
district and showed that the overall HBV and HCV 
sero-prevalence was 15.8% and 5.4% respectively.4 
From the Biostatistics Department of the hospital, the 
prevalence of HBV and HCV in 2007 stood at 15.1% 
and 7.9% respectively (unpublished data). Information 
on HBV and HCV sero-prevalence in Ghana are old, 
scanty or limited to only urban blood donors. The study 
aim was therefore to determine the prevalence of HBV 
and HCV in blood donors in a rural area over a three-




The Agogo Presbyterian Hospital is located in the 
Asante Akim North District of the Ashanti Region of 
Ghana, West Africa; and is the principal hospital of the 
district. The District is located in the eastern part of 
Ashanti Region and covers a land area of 1,160 km2 
with an estimated population of 142,434 (projection 
from 2000 Population Census). The catchment 
population of the hospital encompasses around 70,000 
people, about 25,000 in Agogo itself.  
 
Study population 
Between January 2006 and December 2008, 
Microbiology screening results from 2773 blood 
donors were obtained from the blood bank of the 
hospital. Prospective donors between the ages of 17-60 
years who passed a history screen and pre-donation 
screening test for Hb level, HBV, HCV, Syphilis were 
considered fit to donate blood. 
 
 




The screening of blood donors or donated blood for 
HBsAg and anti-HCV is mandatory thus blood 
donations from individuals who are found to be 
positive for any of the above infections were not done. 
Archived results from the hospitals blood bank was 
used for this study with approval from the hospital 
authorities. The donor samples were tested using the 
DiaSpot® One Step Hepatitis test kits (DiaSpot Rapid 
Diagnosis, Pondok Kelapa 13450, Jakarta Indonesia). 




Data were double-entered into a predesigned electronic 
database using Epi info version 6.04dfr (Center for 
Disease Control, Atlanta, GA, USA) and cleaned. Data 
was exported to Stata/SE9.0 statistical software (Stata 
Corporation, Texas USA) for analysis.  




Ethical approval for the study was obtained from the 
Committee on Human Research, Publication and Ethics 




A total of 2773 prospective blood donors were 
screened from January 2006 to December 2008. Out of 
this, 2556 (92.2%) were males and 217 (7.8%) were 
females. The donors were categorized into five age 
groups (Table 1). Majority of the study population, 
1217 (43.9%) were in the 26 to 35 age group.  
 
 
Table 1 Age categories of the study population over the study period by sex 
 2006 (N=770) 2007 (N=977) 2008 (N=1026) Total (N=2773) 
Age Group 
(yrs) 
Male (%) Male (%) Male (%) Male (%) 
16-25 194 0.89 198 0.84 254 0.84 646 0.85 
26-35 297 0.95 450 0.96 413 0.95 1160 0.95 
36-45 152 0.97 183 0.93 203 0.96 538 0.95 
46-55 64 0.93 61 0.94 61 0.92 186 0.93 
56-65 7 0.54 8 0.80 11 1.00 26 0.76 
Total 714 0.93 900 0.92 942 0.92 2556 0.92 
 
Table 2 The overall prevalence of HBV and/or HCV infection from 2006 to 2008 
 
Overall Prevalence 
Year HBV (%) HCV (%) Both HBV and HCV (%) 
  (95% CI) (95% CI) (95% CI) 
2006 13.8 9.4 1.6 
N= 770 (11.4-16.4) (7.4-11.6) (0.8-2.7) 
2007 11.8 11.1 2.6 
N=977 (9.8-14.0) (9.2-13.2) (1.6-3.6) 
2008 6.9 7 2.2 
N=1026 (5.4-8.6) (5.5-8.8) (1.3-3.2) 
 
Of the total number, 10.53% (292/2773), 5.63% 
(156/2773) and 2.09% (58/2773) were HBV, HCV and 
both HBV and HCV positive respectively.Furthermore, 
the prevalence of co-infection of HBV and HCV 
decreased from 1.6% (95% CI: 0.8-2.7) in 2006 to 
2.2% (95% CI: 1.3-3.2) in 2008 (Table 2).   
 
The overall prevalence rate for HBV was highest in 
2006 (13.8%; 95% CI: 11.4-16.4) but decreased in 
2008 to 6.9% (95% CI: 5.4-8.6). However, the overall 
prevalence of HCV was highest in 2007 (11.1%; 95% 
CI: 9.2-13.2) but decreased to 7.0% (95% CI: 5.5-8.8) 
in 2008. The prevalence rate of HBV was relatively 










Figure 1 Prevalence of HBV and HCV infection 
among males and females  
 
DISCUSSION 
HBV and HCV infections occurrence among blood 
donors in a rural setting was determined by serological 
methods and the results were compared to assess the 
trends in three consecutive years, 2006, 2007 and 2008. 
The prevalence of viral carrier rates in the blood donors 
appears to be different to that of urban blood donors as 
shown in the data with a decrease in HBV and HCV. 
Statistics from earlier studies showed high rates of 
HBV and HCV in urban blood donors.7,8 
 
Our study raises serious concerns regarding the safety 
of the blood supply in our rural communities where 
resources are hard to come by. The decreasing rate of 
positivity to HBV and HCV or both suggests that 
horizontal rather than vertical transmission is the major 
source of this endemicity.9 In areas of low endemicity, 
transmission occurs primarily among young adults10 
and there is an age effect on the prevalence of HBV 
and HCV infections.11  Horizontal transmission of 
HBV and HCV have been related to age, 
socioeconomic conditions, socio professional status 
and risky behaviours such as sharing of bath towels, 
chewing gum, partially eaten candies, or dental 
cleaning materials, as well as biting fingernails in 
conjunction with scratching the backs of carriers.12-14 
 
It has been shown that the improvement of 
socioeconomic conditions may lead to a decreasing 
exposure to HBV and HCV infections14 thus an 
increased risk of HBV and HCV infections might be 
related to an increased exposure to risk factors in 
conjunction with poor sanitary and socioeconomic 
conditions. The decreasing trend of HBV and HCV 
infections in our study population might be due to 
decreased exposure to risk factors in conjunction with 
improving sanitary and socioeconomic conditions. The 
fact that our study community is being educated 
through weekly radio health talk programmes on these 
diseases in terms of good life style practices such us 
having protected sex,  not sharing razors and needles 
with other people among others are being adhered to.  
 
Another possible reason might be the fact that 
screening of blood donors for HBsAg and anti-HCV 
does not totally eliminate the risk of HBV and HCV 
infection through blood transfusion since donors with 
occult HBV and HCV infection that lacked detectable 
levels of HBsAg and anti-HCV15 were screened as 
negative. This emphasizes the need for a more sensitive 
and stringent screening algorithm for blood donations 
even in rural settings.  
 
CONCLUSION 
HBV and/or HCV infection(s) among blood donors in 
the study area is/are reducing. The occurrence of these 
infections among the blood donors should still be 
monitored carefully to further reduce the rates to 
ensure safer and more reliable blood for transfusion. 
Measures such as more sensitive techniques, education, 
sensitization and vaccination must be carried out to 
ensure that people are well enlightened and protected 
from these infections. 
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